Member Login
  1. Stocks
    2. /
  2. Smith & Nephew plc (LSE: SN.)
    3. /

LSE:SN. (Smith & Nephew plc)

About SN.

Medical devices group Smith & Nephew makes nearly half of its revenues through its orthopaedics division, which manufactures knee joints, braces and other supports. Established in 1931, the group now has interests all over the world.
Financial Market Data copyright © 2024 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

    • Smith & Nephew plc (LSE: SN.) Latest News

    Investing Articles

    Is Ekf Diagnostics Holding plc a buy as shares jump 10%+?

    | Peter Stephens

    Should you add Ekf Diagnostics Holding plc (LON: EKF) to your portfolio?

    Read more »

    Investing Articles

    Are these top healthcare stocks in your portfolio?

    | Jack Tang

    These two healthcare stocks are attractive on long-term fundamentals.

    Read more »

    Investing Articles

    Is this the best healthcare stock money can buy after today’s update?

    | Peter Stephens

    Should you buy this stock or a sector peer following today's news?

    Read more »

    Investing Articles

    2 ‘must-have’ healthcare stocks after today’s updates?

    | Peter Stephens

    Should you pile into these two healthcare stocks right now?

    Read more »

    Investing Articles

    Are these 3 shares simply the best Brexit buys after today’s results?

    | G A Chester

    Could these stocks be a cure for Brexit blues?

    Read more »

    Investing Articles

    3 growth stocks still worth buying: Shire plc, Smith & Nephew plc and Coca Cola HBC AG

    | Jack Tang

    Will Shire plc (LON:SHP), Smith & Nephew plc (LON:SN) and Coca Cola HBC AG (LON:CCH) meet their growth expectations?

    Read more »

    Investing Articles

    GlaxoSmithKline plc vs Smith & Nephew plc: which is the FTSE 100’s best medical marvel?

    | Royston Wild

    Royston Wild considers whether investors should pile into FTSE 100 (INDEXFTSE: UKX) giants GlaxoSmithKline plc (LON: GSK) or Smith &…

    Read more »

    Investing Articles

    Should you forget the high valuations and buy FTSE 100 giants Diageo plc, Reckitt Benckiser Group plc and Smith & Nephew plc?

    | Royston Wild

    Royston Wild considers whether investors should pile into FTSE 100 (INDEXFTSE: UKX) stars Diageo plc (LON: DGE), Reckitt Benckiser Group…

    Read more »

    Investing Articles

    Three surprise power plays: Direct Line Insurance Group plc, Smith & Nephew plc and Legal & General Group plc

    | Harvey Jones

    Direct Line Insurance Group plc (LON: DGL), Smith & Nephew plc (LON: SN) and Legal & General Group plc (LON:…

    Read more »

    Investing Articles

    Will AstraZeneca plc, Shire plc and Smith & Nephew plc help you survive Brexit?

    | Peter Stephens

    Should you buy these three stocks ahead of the EU referendum? AstraZeneca plc (LON: AZN), Shire plc (LON: SHP) and…

    Read more »

    Investing Articles

    Are Mediclinic International plc, AstraZeneca plc and Smith & Nephew plc the best FTSE 100 healthcare picks?

    | G A Chester

    G A Chester puts Mediclinic International plc (LON:MDC), AstraZeneca plc (LON:AZN) and Smith & Nephew plc (LON:SN) under the spotlight.

    Read more »

    Investing Articles

    Should you buy Smith & Nephew plc, eSure plc and RSA Insurance Group plc following today’s updates?

    | Royston Wild

    Royston Wild considers the investment appeal of Smith & Nephew plc (LON: SN), eSure plc (LON: ESUR) and RSA Insurance…

    Read more »